Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Your are on :  Markets   |  News Analysis    |  Corporate Results   |Detailed News   
Back
Remedium Lifecare reports standalone net loss of Rs 4.78 crore in the March 2023 quarter
01-Jun-23   16:42 Hrs IST

Net Loss of Remedium Lifecare reported to Rs 4.78 crore in the quarter ended March 2023 as against net loss of Rs 1.16 crore during the previous quarter ended March 2022. Sales rose 87.59% to Rs 75.58 crore in the quarter ended March 2023 as against Rs 40.29 crore during the previous quarter ended March 2022.

For the full year,net profit rose 402.78% to Rs 5.43 crore in the year ended March 2023 as against Rs 1.08 crore during the previous year ended March 2022. Sales rose 1.00% to Rs 509.84 crore in the year ended March 2023 as against Rs 504.79 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
?Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales75.5840.29 88 509.84504.79 1
OPM %-3.84-1.44 -1.470.34 -
PBDT-2.80-0.69 -306 7.551.60 372
PBT-2.81-0.71 -296 7.401.53 384
NP-4.78-1.16 -312 5.431.08 403

Powered by Capital Market - Live News

Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)